GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alzinova AB (STU:78D) » Definitions » Total Liabilities

Alzinova AB (STU:78D) Total Liabilities : €0.82 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Alzinova AB Total Liabilities?

Alzinova AB's Total Liabilities for the quarter that ended in Dec. 2024 was €0.82 Mil.

Alzinova AB's quarterly Total Liabilities increased from Jun. 2024 (€0.74 Mil) to Sep. 2024 (€0.85 Mil) but then declined from Sep. 2024 (€0.85 Mil) to Dec. 2024 (€0.82 Mil).

Alzinova AB's annual Total Liabilities increased from Dec. 2022 (€0.55 Mil) to Dec. 2023 (€0.83 Mil) but then declined from Dec. 2023 (€0.83 Mil) to Dec. 2024 (€0.82 Mil).


Alzinova AB Total Liabilities Historical Data

The historical data trend for Alzinova AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alzinova AB Total Liabilities Chart

Alzinova AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Liabilities
Get a 7-Day Free Trial Premium Member Only 0.47 0.31 0.55 0.83 0.82

Alzinova AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.83 0.72 0.74 0.85 0.82

Alzinova AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Alzinova AB's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities=Total Assets (A: Dec. 2024 )-Total Equity (A: Dec. 2024 )
=11.582-10.765
=0.82

Alzinova AB's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities=Total Assets (Q: Dec. 2024 )-Total Equity (Q: Dec. 2024 )
=11.582-10.765
=0.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alzinova AB Total Liabilities Related Terms

Thank you for viewing the detailed overview of Alzinova AB's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Alzinova AB Business Description

Traded in Other Exchanges
Address
Pepparedsleden 1, Molndal, SWE, SE-431 83
Alzinova AB is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer's disease. The company is engaged in the development of a specific oligomer-directed vaccine (ALZ-101), and ALZ-201 which is a monoclonal antibody that is specific for the toxic AB oligomers. The products of the company are in the clinical and preclinical stages of development as a therapeutic vaccine for the treatment of Alzheimer's.

Alzinova AB Headlines

No Headlines